LES SANDKNOP: Open Payments
NPI 1336139807 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,429 in 153 payments from 27 companies in 2025. Trend: 2023 $2,490 · 2024 $2,484 · 2025 $2,429
Food & beverage: $2,429
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $218 |
| Corium, LLC | 8 | $212 |
| PFIZER INC. | 11 | $209 |
| Sumitomo Pharma America, Inc. | 25 | $208 |
| Amgen Inc. | 18 | $198 |
| Novo Nordisk Inc | 8 | $188 |
| ABBVIE INC. | 19 | $167 |
| Lilly USA, LLC | 11 | $152 |
| Abbott Laboratories | 7 | $149 |
| Corcept Therapeutics | 3 | $105 |
Products named: Azstarys, GEMTESA, Auvelity, FREESTYLE LIBRE 3, MOUNJARO, EVENITY, Korlym, Ozempic.
Industry payments across TX — which companies pay providers there.
